Sales climbed 32% to $306.6 million, about $4 million above analysts' estimates. The company lifted its full-year EPS outlook to $8.20-$8.35, with the midpoint 15 cents above the previous range.
http://ift.tt/1t9KDzI
http://ift.tt/1t9KDzI
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment